A new study conducted by the Medical Research Council (MRC) and the London School of Hygiene & Tropical Medicine (LSHTM) Uganda Research Unit has found that group therapy significantly reduces depression and restores hope among people living with HIV in Uganda. The two-year study, published in 2025, involved participants from several districts across the country.
The research, known as the Group Support Psychotherapy (GSP) trial, showed that participants who received group therapy experienced a 50% reduction in depressive symptoms compared to those who received standard care. The therapy sessions focused on building social support, coping skills, and a sense of community among individuals living with HIV.
Dr. Eugene Kinyanda, the lead researcher, stated that the findings highlight the importance of integrating mental health services into HIV care programs. 'Group therapy provides a cost-effective way to address the high burden of depression among people living with HIV, which can improve adherence to antiretroviral therapy and overall quality of life,' he said.
The study followed over 1,000 participants for 12 months, with results showing sustained improvements in mental health and hope for the future. The MRC/UVRI and LSHTM Uganda Research Unit plans to expand the program to other regions in Uganda and potentially to other African countries.
